Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Contact: Geoffrey Shapiro 877-338-7425
Principal Investigator: Geoffrey Shapiro
Karmanos Cancer Institute
Detroit, Michigan, United States, 48201
Contact: Jas Grewal-Karwa 313-576-8932 karwaj@karmanos.org
Principal Investigator: Anthony Shields
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Contact: Bonnie Chalmers (780) 432-8248 Bonnie.Chalmers@albertahealthservices.ca
Principal Investigator: Quincy Chu
Juravinski Cancer Center
Hamilton, Ontario, Canada, L8V 5C2
Contact: Robin Eady 905-387-9711 ext 64422 ready@HHSC.CA
Principal Investigator: Holger Hirte
Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada, K1H 8L6
Contact: Deborah Keller (613) 247-3518 djonker@toh.on.ca
Principal Investigator: Derek Jonker
University Health Network – Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9
Contact: Amit Oza 416-946-4501 ext 2818
Principal Investigator: Amit Oza
Jewish General Hospital
Montreal, Quebec, Canada, H3T 1E2
Contact: Wilson Miller 514-340-8222
Principal Investigator: Wilson Miller
McGill University Health Centre
Montreal, Quebec, Canada, H4A 3J1
Contact: Nathaniel Bouganim 514-934-1934 ext 35800
Contact: Rosie Santos 514 934-1934 ext: 44328 rosalia.santos@muhc.mcgill.ca
Principal Investigator: Nathaniel Bouganim
Centre Hospitalier de l’Université de Montréal
Montréal, Quebec, Canada, H2X 0A9
Contact: Diane Provencher 514-890-8444 diane.provencher.chum@ssss.gouv.qc.ca
Principal Investigator: Diane Provencher
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
